1. Baskar, S., L. Glimcher, N. Nabavi, R. T. Jones, and S. Ostrand-Rosenberg, 1995: Major histocompatibility complex class H+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181, 619–629.
2. Dexter, D., H. Kowalski, B. Blazar, Z. Fligiel, R. Vogel, and G. Heppner, 1978: Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res. 38, 3174–3181.
3. Aslakson, C., and F. Miller, 1992: Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399–1405.
4. Miller, F., B. Miller, and G. Heppner, 1983: Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis 3, 22–31.
5. Pulaski, B., and S. Ostrand-Rosenberg, 1997: MHC class II and B7.1 immunotherapeutic cell-based vaccine reduces spontaneous mammary carcinoma metastases without affecting primary tumor growth, submitted